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II.

Introduction

Chlamydia trachomatis is an obligate, intracellular pathogen that causes the ocular
infection known as trachoma and the Sexually Transmitted Infection (STI) known as
chlamydia. C. trachomatis is the leading cause of preventable blindness, primarily in
developing nations, and is also the most common cause of reportable, bacterial sexually
transmitted infections both in the United States and world-wide [1]. C. trachomatis
caused over 1.7 million reported cases in the United States in 2018, but including
unreported cases, it is estimated that the total amount of infections reached over 2.86
million [1]. Importantly, two-thirds of chlamydia cases are asymptomatic, making it
difficult to reduce transmission and to prevent people from developing the sequalae
associated with chlamydia. When chlamydial infections go untreated in women, the
severity of the effects increase and can lead to serious diseases such as pelvic
inflammatory disease, cervical cancer in conjunction with HPV infection, ectopic
pregnancies, and infertility [1]. The large number of asymptomatic infections and overall
known disease burden creates an urgent need for prevention methods such as
vaccination. Development of vaccines requires a detailed understanding of how a
pathogen causes disease [11]. However, Chlamydia’s pathogenic mechanisms are
poorly understood, and genetic methods to discover these processes are limited and
cumbersome [4].
C. trachomatis has a unique developmental cycle in which it converts between two
structurally and functionally different forms (Fig 1)[3]. When an infection first begins, C.
trachomatis is in an infectious form known as the Elementary Body (EB). The EB form
utilizes a type 3 secretion system that allows for the bacterium to enter the epithelial cell

leading to formation of a vacuole, called an inclusion, derived from the host’s cellular
membrane. Within the inclusion, C. trachomatis then converts into the larger Reticulate
Body (RB) form. The RB form is the replicative form that allows for bacterial growth and
division. Within the inclusion, RBs will differentiate into the EB form and be released to
infect more cells. If the bacteria are introduced to stressful conditions such as antibiotic
treatment or host immune factors such as IFN-γ, they can enter a stage with low activity
called persistence to ensure survival within the cell [12]. The methods and regulatory
functions necessary to covert between forms and to allow for persistence to occur is not
well known. In addition, growth in the host requires Chlamydia to manipulate the host
cell to provide nutrients for the growing bacterial population while attempting to subvert
the host’s immune response to avoid bacterial clearance [14]. As these collective steps
are critical for pathogenesis, a molecular understanding of these processes could give
rise to improved therapeutics or construction of live-attenuated vaccine strains.

Figure 1. The Biphasic Developmental Cycle of Chlamydia trachomatis. C.
trachomatis differentiates between two distinct forms. The Elementary Body (EB, red)
constitutes the infectious form and allows for the initial infection of a cell and formation
of the inclusion. Within the inclusion, the EB form coverts into the Reticulate Body (RB,
green) which allows for replication within the inclusion. After replications occur, the RBs
will convert back to EBs to exit the cell and continue infecting new cells and new hosts.

A classical approach to delineate pathogenic mechanisms important for
infections caused by C. trachomatis and other pathogens is to genetically modify the

bacterium through gene inactivation. By removing the ability of a gene to function, we
can discover whether the gene is essential for disease and/or its role in bacterial growth
and virulence, and thus determine which genes would be good candidates for vaccine
or antibiotic development. However, for C. trachomatis, only a limited and difficult to
employ genetic tool kit exists, hindering our ability to study pathogenesis [4].
Thus, a goal of my project was to develop an improved mutagenesis system that
creates gene-insertion mutants by utilizing a piece of DNA known as an intron. The
current TargeTron mutagenesis system used in the field is based on the Ll.LtrB group II
intron from Lactococcus lactis [5][6]. It was adapted by our lab for use in C. trachomatis
[7]. Unfortunately, the mutation efficiency of the system is very low, making it difficult to
create mutants in a timely manner. At its best, the Ll.LtrB system has an efficiency of
10-6% when measured in Escherichia coli (Fisher lab, unpublished). My project focused
on developing an alternative intron mutagenesis system for Chlamydia based on the
EcI5 intron from E. coli (Fig 2)[2]. We hypothesized that this system would be an
improvement in Chlamydia over the Ll.LtrB system because EcI5 functions best at
37C, the optimal growth temperature for C. trachomatis, and because preliminary data
from our lab has shown an increase in efficiency using the EcI5 intron in comparison to
the Ll.LtrB system in E. coli. The inability to grow Chlamydia under axenic conditions
makes it difficult to calculate efficiency, so we use E. coli as a surrogate system. My
main aim was to test whether the EcI5 intron will continue to function better than the
Ll.LtrB intron in E. coli after insertion of antibiotic resistance cassettes into the intron,
and whether the EcI5 intron will be more efficient than the Ll.LtrB intron in C.
trachomatis. Antibiotic selection is often essential for identifying mutant bacteria if the

system is of low efficiency or the bacterium cannot be grown under axenic conditions,
which hinders isolation of clones. A minor aim of my project was to determine the “rules”
of EcI5 cargo carrying to aid in use of the EcI5 system with C. trachomatis and other
bacteria.

Figure 2. EcI5 Vector Map. The EcI5 intron is shown on a plasmid with intron
expression controlled by the T7 promoter. The IEP region is located downstream of the
intron. Resistance genes were placed at the MluI restriction enzyme site, which is where
the IEP would be present in the wild type intron isolated from E. coli.

The EcI5 intron is able to find targeted sequences within a genome by utilizing
the associated Intron Encoded Protein (IEP) in conjunction with sequence information in
the 5’ region of the intron. It is the 5’ “targeting” sequence that researchers modify to
target the intron to different genes. Once the EcI5 intron and its IEP have been
transcribed and the IEP open reading frame has been translated, a lariat is formed that

contains a protein part and an RNA part, known as a ribonucleoprotein [9]. The RNA
portion is used to scan for targeted insertion sites within the genome via RNA-DNA
base pairing. Once the binding site is found, the endonuclease activity of the IEP cuts
both strands of the double stranded DNA target. Two more enzyme activities of the IEP,
RNase and reverse transcriptase activities, allow for the insertion of the intron RNA into
the cut area followed by conversion of the RNA to DNA. Once the intron is in the single
stranded DNA form, the host cell’s replication system can replicate the intron DNA
generating double stranded DNA containing the intron-disrupted gene (Fig 3).
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Figure 3. EcI5 mobility. EcI5 intron transcription is induced and EcI5 and intron
encoded protein (IEP) transcripts are produced. The IEP transcript is then translated,
and the IEP protein processes the EcI5 RNA to form a ribonucleoprotein lariat. The RNA
portion has a 5’ located targeting sequence that scans the host chromosome for its
unique insertion site. The IEP then provides endonuclease, reverse transcriptase,
and RNase activities to mediate intron insertion.

III. Results
We first confirmed that the wild-type EcI5 system performed at the high efficiencies
reported by Zhuang et al. [2]. The intron was targeted to the lacZ gene (encodes βgalactosidase) to allow for blue (wild type) -white (insertion mutant) colony screening on
LB agar plates with the β-galactosidase colorimetric substrate X-gal. The 1806-1807
lacZ insertion site was chosen for targeting, which should give rise to a sense intron
insertion (http://www.targetrons.com/lacZ-EcI5-results.txt). Insertion efficiencies
determined by counting white versus blue colonies were routinely above 70% (Table 1).
Insertions were confirmed by performing PCR on randomly selected white colonies (Fig
4).
Next, we sought to determine the “rules” of the EcI5 mutagenesis system through
the use of alternative intron designs and induction protocols. We selected the aadA
(spectinomycin resistance), bla (ampicillin resistance), and cat (chloramphenicol
resistance) genes for our study due to previous validation of these markers in the Ll.LtrB
system with C. trachomatis or Chlamydia caviae [7][8][15]. All markers were either
restriction digested or PCR-amplified from the pDFTT-Ll.LtrB vectors and ligated into
the MluI digested lacZ-targeted EcI5 vector. Plasmids were selected that carried the
genes in sense or anti-sense orientations to the intron and transformed into the E. coli
BL21(de3) expression strain for intron mobility studies. The vector constructs are shown
in Fig 5.

Figure 4: PCR analysis of potential mutant colonies. PCR was performed using
a lacZ primer and an intron primer to assess intron insertion. PCR products were
resolved on 0.8% agarose gels, stained with ethidium bromide, and visualized using UV
light. (A) A plate from the EcI5 positive control group was checked for white and blue
colonies. White colonies have the intron insertion, while blue colonies have an
uninterrupted lacZ gene. (B) One white colony from the aadA sense construct grown
under the 3 hour + 1.0 mM IPTG condition was tested for EcI5 intron insertion. The 1.3
kbp product supported that intron insertion occurred. (C) White colonies from the aadA
RBS and ORF constructs grown under the 3 hour + 0.1mM IPTG were also tested for
EcI5 intron insertion. The results came back positive with bands at 1.3 kbp, matching
the expected size of the insertion product. Molecular weight markers are shown to the
left of each gel in (B) and (C).

Figure 5. EcI5 constructs. (A) Diagram of the wild type EcI5 intron with the IEP
encoded within the intron. (B) The recombinant EcI5 mutants encoding an
antibiotic resistance gene in place of the IEP region. The IEP is cis encoded
downstream of the intron. (C) This figure illustrates the aadA RBS, aadA ORF,
the aadA-3’, RAM, and RAMr constructs. The ORF construct is promoter-less
and does not contain an RBS. The RBS construct is promoter-less but contains
the RBS.
We found that the EcI5 vectors encoding the full aadA and bla antibiotic resistance
genes (promoter, ribosomal binding site, open reading frame, and terminator sequence)
within the intron at the MluI site produced lacZ-insertion efficiency rates that were under
1% or were below our limit of detection of 0.01% (Table 1). These efficiencies were well
below the non-antibiotic carrying intron, which inserted at an efficiency of ~70% (Table
1). Note that the MluI site corresponds to where the EcI5 intron would have carried the

intron-encoded protein (IEP, Fig 2). For mutagenesis purposes, the IEP is encoded
downstream from the intron. Note that the IEP would not possess a promoter sequence
when encoded within the EcI5 as expression would rely on the intron promoter. For the
mutagenesis system, the intron promoter is lost upon gene intron insertion into the
chromosome and any cargo within the intron would need its own promoter for
expression.
Since insertion efficiencies were low with the resistance cassette constructs, we next
varied the incubation intervals and inducer concentrations to determine if growth and
induction conditions affected insertion efficiency. In one trial, we produced one mutant
colony from the aadA sense construct after a 3-hour incubation condition with 1.0 mM
IPTG (inducer), suggesting that the sense orientation might be preferred (Table 1, Fig
4). This result also supports that the efficiency rates of the EcI5 mutagenesis system
could represent a large improvement over the previous Ll.LtrB system, which had a
maximum insertion efficiency of 10-6%. We also tested a smaller antibiotic cassette, the
cat gene, to see if cargo size (975 bp cat, 1.2 kbp bla, 1.3 kbp aadA) was negatively
impacting mobility. This construct did not make a difference in insertion efficiency as
rates were still less than 2.9-2%. During these experiments, we observed that growth of
the recombinant E. coli strains was reduced with high levels of IPTG (1.0 mM IPTG) and
that all of the strains tested seemed to grow best with the 3-hour incubation time, so we
made the 3 hour incubation standard for the rest of the trials using the modified
resistance cassettes.

Table 1. Insertion efficiency assay results for aadA (sense and antisense), bla
(sense), and cat (sense and antisense) vectors

As the IEP would not possess an internal promoter in the wild type intron, we
hypothesized that the resistance gene promoters might be interfering with intron
mobility. To test our hypothesis, we developed new constructs lacking the promoter
(aadA RBS), both the promoter and RBS (aadA ORF), or the 3’ region (aadA-3, data not
shown) of the antibiotic resistance gene. We used the sense orientation of the aadA
resistance gene because we had seen one positive mutant colony in our previous
results (Fig 4). All constructs were grown for 3 hours with 0.1 mM IPTG or 1.0 mM
IPTG. The ORF and RBS constructs produced mutant colonies (Fig 4), and the insertion
efficiency levels began to approach the efficiency levels of the wild type EcI5 intron

lacking a resistance gene insert (Fig 6). The aadA-3 construct, which still encoded the
promoter and RBS, yielded no white colonies (efficiency <0.24%, personal
communication from Derek Fisher). These results suggested that there might be
promoter competition between the intron promoter and the antibiotic resistance gene
promoter leading to low expression of the full-length intron.

Figure 6. Insertion efficiency assays of aadA RBS (sense and antisense) and
aadA ORF (sense and antisense). (A) White colonies were seen for each construct
under 3 hours + 0.1mM IPTG. The number of white colonies per total colonies was used
to calculate insertion efficiency. (B) White colonies were also observed for each
construct under 3 hours + 1.0 mM IPTG.

To attempt to block promoter competition, we decided to insert a Retrotransposable
Activated Marker (RAM) within the promoter region. A RAM cassette is a 400-base pair,
type I intron that has the ability to self-splice out of a region of RNA upon transcription
[10]. In our system, we placed the RAM cassette between the -35 and -10 regions of the
bla antibiotic resistance gene promoter. The bla gene was selected rather than the
aadA gene as the bla promoter is well characterized. We hypothesized that the RAM

intron would cause the promoter region to be unrecognizable within the DNA allowing
for unfettered transcription from the intron promoter. After transcription, the RAM should
self-splice reconstituting function of the antibiotic resistance gene. We also wanted to
determine if the orientation of the antibiotic resistance gene in reference to the RAM
cassette played a role in insertion efficiency. We utilized the bla antibiotic resistance
gene in the antisense orientation with the RAM cassette inserted into its respective
promoter region. Neither use of the RAM cassette or RAM orientation rescued intron
insertion efficiency (Tables 2 and 3).

Table 2. Insertion efficiency assay results for RAM vector.

Table 3. Insertion efficiency assay results for RAMr vector.

IV. Discussion
Current methods for mutagenesis in C. trachomatis include our intron approach,
transposon mutagenesis, allelic exchange, chemical mutagenesis, and TILLING
[7][13] [16][17][18]. While useful, all of these approaches have limitations, and none
have been uniformly adopted across the field. In this study, our goal was to create a
new intron mutagenesis system for Chlamydia based on the EcI5 intron from E. coli.
Although we were not able to create a system that was functional and provided a
means of selection within Chlamydia, we were able to discover rules associated with
the EcI5 system.
The study began by developing the bla (sense), aadA (sense & antisense), and
cat (sense & antisense) vectors by utilizing restriction enzyme digestion at the MluI
site on the plasmid. We then tested these vectors for intron mobility at various
induction periods and concentrations of the inducing agent, IPTG, within E. coli. We
found that the constructs with antibiotic resistance markers had insertion efficiency
rates that were significantly lower than the construct with the wild type intron, as we
were unable to detect mutants with the exception of one trial. This one success in E.
coli was still a drastic improvement over the Ll.LtrB system. The results also show
an ~106-fold improvement in insertion efficiency with the marker-less EcI5 over the
Ll.LtrB intron in E. coli. Upon the addition of resistance genes, the insertion
efficiency was significantly reduced, regardless of orientation. This suggests that
there could be competition between the resistance gene promoter and the intron
promoter. Alternatively, placing genes within the IEP region of the intron might cause
issues with lariat folding, also resulting in decreased efficiency.

In order to determine the cause of the decrease in efficiency, we created
constructs that removed either the promoter regions, ribosomal binding site, or both
areas within the antibiotic resistance gene in the intron. Like the previous constructs,
these were also made by utilizing restriction enzyme digestion at the MluI site on the
plasmid. Vectors were then tested at the two testing conditions that worked best in
the original experiments, 3hr + 0.1mM IPTG & 3hr + 1.0 mM IPTG. We found that
the promoter-less construct (aadA RBS) and a construct without a promoter or RBS
(aadA ORF) had efficiency rates close to the wild type levels suggesting that a
smaller insert and/or lack of a promoter within the IEP region was preferred. We also
assessed the impact on mobility of sequences 3’ to the antibiotic gene ORF.
Removal of the 3’ sequence did not result in improved efficiency. Note that the 3’
constructs still encoded the antibiotic gene promoter and RBS. Overall, the results
suggest that including the promoter region significantly reduces insertion efficiency.
Although the EcI5 intron system appears more efficient than Ll.LtrB with the aadA
ORF and aadA RBS constructs, lacking a promoter for the antibiotic resistance gene
would cause problems in the future when attempting to select for mutants in C.
trachomatis.
Finally, we attempted to transiently inactivate the promoter region of the antibiotic
resistance gene until after transcription of the intron and IEP has occurred. To do
this, we utilized a Retrotransposable Activated Marker that was inserted to interrupt
the promoter region of the resistance gene, making it unrecognizable to the RNA
polymerase during transcription from the intron-carrying plasmid. Following
transcription, the RAM cassette should self-splice out of the RNA and allow for the

promoter to be recognizable again after the intron inserts into the targeted gene,
enabling the selection of mutants. However, our results showed that we were unable
to detect any mutants with this construct, suggesting that either the promoter being
present following transcription still posed a problem or that the RAM cassette was
not functioning as predicted.
Based on the results of this study, we can conclude that the EcI5 group IIB intron
mutagenesis system does provide a higher insertion efficiency than the previously
used Ll.LtrB L. lactis system when used in E. coli. However, insertion of a second
promoter within the intron drastically decreases insertion efficiency. It should be
noted that the Ll.LtrB intron used for comparison to the EcI5 intron carries a kanRAM cassette, which could impact insertion efficieny. Future work should focus on
further developing and improving upon the RAM system to resolve the promoter
competition issue. We should also utilize the ORF construct previously made to
create mutations by placing it under the control of the targeted gene’s promoter to
transcribe and translate the selection marker within the intron, thus giving us
selectable mutants at a higher efficiency than the previous Ll.LtrB system.

V.

Methods
Strains and growth conditions:
E. coli NEB10 (New England BioLabs) was used for cloning steps and was

routinely cultured at 37°C in LB broth or on LB agar plates in the presence of 20
µg/mL chloramphenicol when carrying vectors (Fig 5). Vectors were transformed into
the E. coli BL21(de3) expression strain and grown as described in the results section for
mobility experiments. LB agar plates containing 40 µg/mL X-gal and 20
µg/mL chloramphenicol were used for blue-white screening. Plates were incubated at
37°C for 24 hours prior to blue-white assessment.
Vector Construction:
The EcI5 Group IIB intron from E. coli is able to splice and insert itself into
specific, targeted locations within bacterial chromosome with the help of an IntronEncoded Protein (Fig 3). Our EcI5 intron was targeted to the lacZ gene (encoding betagalactosidase) using the gBlock approach described in http://www.targetrons.com/lacZEcI5-results.txt. Targeting to this gene enabled a screening method to help identify the
desired mutants. The lacZ encoded β-galactosidase is utilized to break down lactose,
and in our case, the colorimetric substance X-gal, which leads to the production of a
blue color within the colonies. Colonies that grew blue on the plate had a normal lacZ
gene and β-galactosidase activity and could breakdown the X-gal within the media.
Colonies that grew white had the EcI5 intron interrupting the lacZ gene and thus could
not utilize the X-gal. White colonies were PCR verified to ensure that the intron had
inserted into the correct location. Primers for the lacZ-EcI5 PCR are listed in Table 4.

Thermo Scientific PCR Master Mix was used for colony PCR reactions and the primers
were used at 0.5 µM (primers were ordered from Integrated DNA Technologies).
Within the intron, we placed various antibiotic resistance markers to allow for
selection of mutants. Clones were designed using CloneManager software. Cloning
PCR reactions used Phusion polymerase (Thermo Scientific). Resistance markers were
chosen based on their success within the L. lactis intron [7][8][15]. Genes or PCR
products for the bla (sense), aadA (sense & antisense), cat (sense &
antisense), aadA RBS (sense and antisense), aadA ORF (sense and antisense), and
aadA-3 were digested with MluI and ligated into similarly digested plasmids. Ligation
products were transformed into E. coli NEB10. To construct the bla RAM vector, the
RAM intron was PCR amplified from pACD4-K and the bla vector was PCR amplified
using primers with 20 bp overlaps with the RAM cassette. Both PCR products were then
linked using the NEB HiFi DNA assembly as directed by the manufacturer (New
England BioLabs). E. coli transformants were screened by PCR for insert presence and
orientation relative to the intron (primers in Table 4) and plasmids were then isolated for
Sanger DNA sequencing (performed by PSOMAGEN). Sequence-verified vectors were
then transformed into E. coli BL21(de3) for intron mobility testing.

Table 4. lacZ detection and gene cloning primers
Gene Forward primer
Reverse Primer
aadA TCTACGCGTTGCCTGACGATG GTAACGCGTCCCGGGCCTGA
CGTGGAG
TAGTTTGGCTGTGAG
bla

cat

aadA
ORF
aadA
RBS
aadA
-3
bla
vect
or
RAM

lacZEcI5
Univ
EcI5
F

Notes
MluI
site in
italics
TCGCACGCGTAGGTTAATGTC
GACACGCGTGTGGAACGAAA MluI
ATGATAATAATGG
ACTCACG
site in
italics
GCGACGCGTGCTATAAATTTTT CCCAACGCGTAAAAGGATGG MluI
AAAAATAGCAG
TCGTAAG
site in
italics
CAAACGCGTATGCGCTCACGC GTGACGCGTTTATTTGCCGAC MluI
AACTGG
TACCTTG
site in
italics
CAAACGCGTCTGTAATGCAAGT GTAACGCGTCCCGGGCCTGA MluI
AGCGTATGCGCTCAC
TAGTTTGGCTGTGAG
site in
italics
TCTACGCGTTGCCTGACGATG GTGACGCGTTTATTTGCCGAC
CGTGGAG
TACCTTG
GACCTTATCTGAACATAATGCT GGCCTCAATTAACCCAAGAAA overla
CATGAGACAATAACC
TTTGAATGTATTTAG
p in
italics
TTCTTGGGTTAATTGAGGCCTG CATTATGTTCAGATAAGGTCG overla
AG
TTAATCTTAC
p in
italics
TGGTCTGCTGCTGCTGAACG
ATCCGGTCCATTACAGACTGG
CATTCG
CCCCTCTAGAAGAATTCCCATG
insert
CCAAA
orient
ation
PCR
match
ed
with
gene
primer

Mobility Assay:
The recombinant BL21(de3) strains were grown overnight in LB with 20
µg/mL chloramphenicol at 37°C. 50 µL of bacteria were then subcultured into 5 ml LB
with 20 µg/mL chloramphenicol and grown until an optical density at 600nm of 0.2-0.3
was reached. 200 µL of bacteria were then subcultured in 5 mL LB with 20
µg/mL chloramphenicol and the test amount of IPTG. The subculture was grown for
different time periods prior to dilution in PBS to ~1,000 CFU/ml and plating of 100 µl on
LB agar plates containing 40 µg/mL X-gal and 20 µg/mL chloramphenicol. OD 600nm
readings were used to estimate bacterial numbers prior to dilution (OD 600nm 1 = 5x10 8
CFU/ml). Plates were incubated at 37°C for 24 hours prior to analysis. Colonies
containing mutant bacteria would remain white while nonmutants would have no
interruption of the lacZ gene and would be able to break down the X-gal, giving rise to
blue colonies. For any white colonies, orientation PCR was performed using the forward
primer, LacZ F2, and the reverse primer, UnivEcIR, to confirm the presence of the EcI5
intron. The PCR samples were run on a 0.8% agarose gel for 30 minutes, stained with
ethidium bromide, and visualized with UV transillumination.
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